Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
7
×
life sciences
medicare
7
×
national
7
×
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
eli lilly
fda
bristol-myers squibb
cancer immunotherapy
deals
nivolumab
startups
amgen
biotech ipos
gene therapy
What
bio
roundup
companies
drug
new
week
alzheimer’s
biotech
hasn’t
ipo
life
market
research
science
advantages
annual
appetite
approval
arena’s
arrival
assessed
attention
bar
biogen’s
biopharmaceutical
black
bounty
bread
brings
butter
buyout
cancer
cash
cig
comeback
communities
conference
congress
convo
corner
Language
unset
Current search:
medicare
×
national
×
" clinical trials "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More